Literature DB >> 16547690

Sjögren's syndrome in patients with ankylosing spondylitis.

Senol Kobak1, Arzu Celebi Kobak, Yasemin Kabasakal, Eker Doganavsargil.   

Abstract

There are few reports about the coexistence of Sjögren's syndrome (SS) and ankylosing spondylitis (AS). To evaluate the frequency of SS in patients with AS. We studied 70 patients with AS presenting to the university outpatient clinic between January 2002 and November 2003. All the patients were asked about sicca symptoms by using sicca questionnaire. Rheumatoid factor, anti-nuclear antibody, anti-Ro, and anti-La antibodies were examined for each of the patients. Salivary flowmetry for the existence of xerostomia, Schirmer's test, and break-up time for the existence of xerophtalmia were performed in all patients with AS. Minor salivary gland biopsy was performed on the patients with at least three positive responses to the sicca questionnaire and positive xerostomia/xerophtalmia tests. Biopsies were regarded as pathological when they showed focal grade iii and grade IV sialoadenitis according to Chisholm grading criteria. Among 70 AS cases, 56 (80%) were men, 14 (20%) were women, and the mean age was 42 years old. Minor salivary gland biopsy was performed on the 16 patients. Of 16 minor salivary gland biopsies, 7 were assessed as pathological--5 of them showed grade III, and 2 of them showed grade IV sialoadenitis. Of these seven patients, one was anti-Ro-positive, and two were anti-La-positive. There was no patient with normal salivary gland biopsy and anti-Ro and/or anti-La positivity. In our study group, 7 (10%) of 70 AS patients had concomitant SS. Therefore, it seems likely that AS may have pathogenetic association with SS.

Entities:  

Mesh:

Year:  2007        PMID: 16547690     DOI: 10.1007/s10067-006-0255-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  16 in total

Review 1.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

2.  Increased frequency of Sjögren's syndrome in patients with spondyloarthropathy.

Authors:  J Brandt; M Rudwaleit; U Eggens; A Mertz; A Distler; J Sieper; J Braun
Journal:  J Rheumatol       Date:  1998-04       Impact factor: 4.666

3.  Antinuclear antibodies in ankylosing spondylitis, psoriatic arthritis, and psoriasis.

Authors:  J N Rosenberg; G D Johnson; E J Holborow
Journal:  Ann Rheum Dis       Date:  1979-12       Impact factor: 19.103

4.  Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community.

Authors:  C Vitali; S Bombardieri; H M Moutsopoulos; G Balestrieri; W Bencivelli; R M Bernstein; K B Bjerrum; S Braga; J Coll; S de Vita
Journal:  Arthritis Rheum       Date:  1993-03

5.  Sjögren's syndrome in seronegative spondyloarthropathies: an unusual finding.

Authors:  S E Gusis; N G Villa; J A Maldonado Cocco; H A Barceló; E J Scheines; L J Catoggio; C Moreno; C Ravaglia; J Palioni
Journal:  J Rheumatol       Date:  1994-04       Impact factor: 4.666

6.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

Review 7.  Xerostomia and hyposalivation: causes, consequences and treatment in the elderly.

Authors:  T O Närhi; J H Meurman; A Ainamo
Journal:  Drugs Aging       Date:  1999-08       Impact factor: 3.923

8.  Salivary gland hypofunction in elderly patients attending a xerostomia clinic.

Authors:  L P Longman; S M Higham; K Rai; W M Edgar; E A Field
Journal:  Gerodontology       Date:  1995-12       Impact factor: 2.980

9.  Increased frequency of leukocyte-reactive antinuclear antibody in patients with ankylosing spondylitis.

Authors:  F B Vasey; T D Kinsella
Journal:  J Rheumatol       Date:  1977       Impact factor: 4.666

10.  Is the relationship between spondyloarthropathy and Sjögren's syndrome in women coincidental? A study of 13 cases.

Authors:  Claire Scotto di Fazano; Rose-Marie Grilo; Pascale Vergne; Damien Coyral; Richard Inaoui; Christine Bonnet; Philippe Bertin; Richard Trèves
Journal:  Joint Bone Spine       Date:  2002-06       Impact factor: 4.929

View more
  6 in total

Review 1.  Ankylosing spondylitis: Chinese perspective, clinical phenotypes, and associated extra-articular systemic features.

Authors:  Huei-Huang Ho; Ji-Yih Chen
Journal:  Curr Rheumatol Rep       Date:  2013-08       Impact factor: 4.592

Review 2.  Ankylosing spondylitis coexists with rheumatoid arthritis and Sjögren's syndrome: a case report with literature review.

Authors:  Guo Wang Zhao; Lin Fang Huang; Dian Li; Yan Zeng
Journal:  Clin Rheumatol       Date:  2020-09-16       Impact factor: 2.980

3.  Spondyloarthropathies in autoimmune diseases and vice versa.

Authors:  Oscar M Pérez-Fernández; Rubén D Mantilla; Paola Cruz-Tapias; Alberto Rodriguez-Rodriguez; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  Autoimmune Dis       Date:  2012-02-15

4.  Coexistence of Sjögren syndrome in patients with synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: A retrospective observational study.

Authors:  Lun Wang; Yanying Yu; Shuo Zhang; Wen Zhang; Chen Li
Journal:  Medicine (Baltimore)       Date:  2021-03-26       Impact factor: 1.817

5.  Association of the Risk of Primary Sjögren's Syndrome With Fibrocystic Breast Disease: A Nationwide, Population-Based Study.

Authors:  Hsin-Hua Chen; Hsian-Min Chen; Ching-Heng Lin; Kuo-Tung Tang; Der-Yuan Chen; James Cheng-Chung Wei; Wen-Cheng Chao
Journal:  Front Med (Lausanne)       Date:  2021-07-01

6.  Improvement of conjunctival cytological grade and tear production in Ankylosing Spondylitis patients under TNF inhibitors: a long-term follow-up.

Authors:  Fany Solange Usuba; Carla Gonçalves Schahin Saad; Nadia Emi Aikawa; Priscila Novaes; Julio Cesar Bertacini Moraes; Ruth Miyuki Santo; Jozelio Freire Carvalho; Eloisa Bonfá; Milton Ruiz Alves
Journal:  Sci Rep       Date:  2020-01-15       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.